Status:
UNKNOWN
To Evaluate Transoral Flexible Endoscope With Narrow Band Imaging in Nasopharyngeal Cancer
Lead Sponsor:
Chinese University of Hong Kong
Conditions:
Nasopharyngeal Carcinoma
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Nasopharyngeal carcinoma (NPC) is endemic in our region and is the 9th most common cancer in Hong Kong. Traditionally diagnosis has been through a nasoendoscopic examination of the nasopharynx with wh...
Detailed Description
This is a case-control pilot study. We will recruit 40 patients. 20 patients with newly diagnosed primary NPC will be recruited to the test group. 20 patients undergoing an OGD for lesions not involvi...
Eligibility Criteria
Inclusion
- General Inclusion Criteria for both study groups, Test group and Control group.
- No previous radiotherapy to the head and neck region
- 18 Years and older
- Able to provide informed consent
- No cognitive impairment
- Test group - Specific Inclusion Criteria 1) Newly diagnosed primary nasopharyngeal carcinoma
- Control group - Specific Inclusion Criteria
- 1\) Patients undergoing an OGD for lesions not involving disease of the head and neck region
- General Exclusion Criteria for both study groups, Test group and Control group.
- On anticoagulation including Plavix, warfarin and NOAC's
- Current mucosal lesions of the head and neck region
- History of malignancy
- Concomitant malignant disease
- Trismus preventing an OGD
Exclusion
Key Trial Info
Start Date :
June 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2021
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04419324
Start Date
June 1 2020
End Date
May 1 2021
Last Update
June 5 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.